Ignite Creation Date:
2024-05-06 @ 4:17 PM
Last Modification Date:
2024-10-26 @ 2:07 PM
Study NCT ID:
NCT04930094
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-09
First Post:
2021-06-15
Brief Title:
Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo in Combination With Glucocorticoid Taper Regimen in Patients With Giant Cell Arteritis GCA
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-06
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07-02
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-15
First Submit QC Date:
June 15 2021
Study First Post Date:
2021-06-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-09
Last Update Post Date:
2024-07-09
Last Update Post Date Type:
ACTUAL